Equitable Holdings’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$797K Buy
7,007
+1,460
+26% +$166K 0.01% 863
2025
Q1
$583K Buy
5,547
+1,833
+49% +$193K 0.01% 872
2024
Q4
$398K Buy
3,714
+1,128
+44% +$121K ﹤0.01% 944
2024
Q3
$259K Buy
+2,586
New +$259K ﹤0.01% 1092